Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype.
Azevedo O, Gal A, Faria R, Gaspar P, Miltenberger-Miltenyi G, Gago MF, Dias F, Martins A, Rodrigues J, Reimão P, Pereira O, Simões S, Lopes E, Guimarães MJ, Sousa N, Cunha D.
Azevedo O, et al.
Mol Genet Metab. 2020 Feb;129(2):150-160. doi: 10.1016/j.ymgme.2019.07.012. Epub 2019 Jul 24.
Mol Genet Metab. 2020.
PMID: 31519519
Free article.